Gujarat Kidney And Super Speciality reported H1 F527 consolidated revenue from operations of 72.4 crore, up 157% year-on-year. It acquired a 51% stake in a Dubai polyclinic with an existing revenue base of approximately 20 crore.
GKSL · Gujarat Kidney And Super Speciality Limited
Volume · Nov 13
7986
Avg daily vol (3M)
76.63K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close156.15 INR
Open158.30 INR
Day155.00–158.30 INR
Available close range99.95–194.25 INR
Avg vol 30d90K
Last earningsNov 5, 2026
DataDec 2025–Nov 2026
The closing range uses available history since Dec 30, 2025; less than a full year is stored.
Latest documents
2026
Nov 5
Earnings call
Revenue doubles as expansion broadens into Dubai
Quarterly results
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its available closing range
Range low 99.95 INR
Now 156.15 INR · 60%
Range high 194.25 INR
vs 200-day avg +14%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XBOM:GKSL | +0.2% | -17.5% | +9.1% | -4.5% | +52.0% |
Exchange listing
- Market
- XBOM
- Ticker
- GKSL
- ISIN
- INE0V0W01025
- Security
- Ordinary share
- Trading currency
- INR
Company
- Investor relations
- https://www.gujaratsuperspecialityhospital.com/financial
Other listings of this company
Share classes and depositary receipts can have different prices and dividends.
Recent dividends
No verified dividend payments are available for this listing yet.
Upcoming investor events
No upcoming investor events are listed for this company yet.
Earnings calls
-
Earnings call · Q2 2027 2026-11-05 Audio TranscriptEarnings Call for the Quarter Ended September 30, 2026